Wednesday, 29 November 2017

Health secretary nominee Azar says drug pricing a top priority

WASHINGTON (Reuters) - Alex Azar, a former drug industry executive who Republicans have nominated to run the U.S. Department of Health and Human Services, on Wednesday promised to lower drug prices that he said are too high, saying he would look at abuse of patent laws that delays generic competition.


from Reuters: Health News http://ift.tt/2BvAPND

No comments:

Post a Comment